181 related articles for article (PubMed ID: 16314433)
1. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.
Routes JM; Ryan S; Morris K; Takaki R; Cerwenka A; Lanier LL
J Exp Med; 2005 Dec; 202(11):1477-82. PubMed ID: 16314433
[TBL] [Abstract][Full Text] [Related]
2. MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection.
Routes JM; Ryan JC; Ryan S; Nakamura M
Int Immunol; 2001 Oct; 13(10):1301-7. PubMed ID: 11581175
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D.
Korrer MJ; Routes JM
Results Immunol; 2015; 5():1-5. PubMed ID: 25685658
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
[TBL] [Abstract][Full Text] [Related]
5. The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity.
Miura TA; Cook JL; Potter TA; Ryan S; Routes JM
J Cell Biochem; 2007 Mar; 100(4):929-40. PubMed ID: 17063489
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions.
Backström E; Chambers BJ; Ho EL; Naidenko OV; Mariotti R; Fremont DH; Yokoyama WM; Kristensson K; Ljunggren HG
Eur J Immunol; 2003 Jan; 33(1):92-100. PubMed ID: 12594837
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL).
Routes JM; Ryan S; Clase A; Miura T; Kuhl A; Potter TA; Cook JL
J Immunol; 2000 Oct; 165(8):4522-7. PubMed ID: 11035092
[TBL] [Abstract][Full Text] [Related]
9. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
[TBL] [Abstract][Full Text] [Related]
10. Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development.
Routes JM; Ryan S; Li H; Steinke J; Cook JL
Virology; 2000 Nov; 277(1):48-57. PubMed ID: 11062035
[TBL] [Abstract][Full Text] [Related]
11. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism.
Takaki R; Hayakawa Y; Nelson A; Sivakumar PV; Hughes S; Smyth MJ; Lanier LL
J Immunol; 2005 Aug; 175(4):2167-73. PubMed ID: 16081783
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
[TBL] [Abstract][Full Text] [Related]
13. Expression of an E1A/E7 chimeric protein sensitizes tumor cells to killing by activated macrophages but not NK cells.
Miura TA; Li H; Morris K; Ryan S; Hembre K; Cook JL; Routes JM
J Virol; 2004 May; 78(9):4646-54. PubMed ID: 15078947
[TBL] [Abstract][Full Text] [Related]
14. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.
Westwood JA; Kelly JM; Tanner JE; Kershaw MH; Smyth MJ; Hayakawa Y
J Immunol; 2004 Jan; 172(2):757-61. PubMed ID: 14707044
[TBL] [Abstract][Full Text] [Related]
16. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
[TBL] [Abstract][Full Text] [Related]
17. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.
Ogasawara K; Benjamin J; Takaki R; Phillips JH; Lanier LL
Nat Immunol; 2005 Sep; 6(9):938-45. PubMed ID: 16086018
[TBL] [Abstract][Full Text] [Related]
18. NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function.
Abdool K; Cretney E; Brooks AD; Kelly JM; Swann J; Shanker A; Bere EW; Yokoyama WM; Ortaldo JR; Smyth MJ; Sayers TJ
J Immunol; 2006 Aug; 177(4):2575-83. PubMed ID: 16888019
[TBL] [Abstract][Full Text] [Related]
19. Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.
Routes JM; Morris K; Ellison MC; Ryan S
J Virol; 2005 Jan; 79(1):116-23. PubMed ID: 15596807
[TBL] [Abstract][Full Text] [Related]
20. NKG2D function protects the host from tumor initiation.
Smyth MJ; Swann J; Cretney E; Zerafa N; Yokoyama WM; Hayakawa Y
J Exp Med; 2005 Sep; 202(5):583-8. PubMed ID: 16129707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]